Advertisement
Certificate of Psychedelic and Contemplative Therapies (CPACT)The BioMedical Institute of Yoga and Meditation, BIYOME
Brisbane Face To Face, Brookfield Retreat.
BIYOME has collaborated with The Signs of Life Psychology to offer a Psychedelic-Assisted Therapy (PAT) training course that is crafted in alignment with emerging Australian standards.
As dedicated course providers, we adhere to current Australian guidelines, ensuring a commitment to the safe, ethical, and efficacious integration of psychedelic-assisted therapy. The course was formed in response to the rescheduling of MDMA and psilocybin as a peak multidisciplinary body for psychedelic-assisted therapy (PAT) in Australia. Australia is in the process of establishing national standards for Psychedelic-Assisted Psychotherapy (PAP) credentialing. BIYOME and The Signs of Life Psychology will continue to offer professional development and ongoing learning options to ensure our course keeps up to date with requirements.
Our extensive course not only meets the emerging Australian standards but also plays a proactive role in meeting the increasing training demand for authorised prescribers of psychedelic-assisted therapy. BIYOME is utilising the most up-to-date research, clinical and community practice regarding what fundamental education for PAT administrators, therapists, and facilitators involves.
Our mission is grounded in the safe integration of psychedelic-assisted therapy into mental health care to alleviate persistent mental health challenges. These challenges not only impose significant financial burdens on the healthcare system but also deeply impact individuals and their families throughout their lives.
In both Australia and on a global scale, there is a dynamic and expanding body of research in the field of psychedelic science. The potential of psychedelic therapy is particularly promising in addressing chronic conditions that affect a large segment of the population and could serve to alleviate the strain on healthcare resources.
As of July 1, 2023, authorised psychiatrists in Australia can legally access products containing 3,4-methylenedioxy-methamphetamine (MDMA) for the treatment of traumatic stress disorder (PTSD) and psilocybin for treatment-resistant depression. This decision reflects research showing MDMA has demonstrated efficacy in addressing post-traumatic stress disorder, while psilocybin shows promise in treating individuals with treatment-resistant depression.
Moreover, ongoing studies are delving into the capacity of MDMA and psilocybin to address recovery from addiction and psilocybin to assist in the treatment of pain disorders, eating disorders, and obsessive-compulsive disorder. These newer investigations continue to expand, offering promising avenues for expanding the therapeutic applications of psychedelics, reinforcing their potential to bring about transformative changes in mental health and overall well-being.
Join us in shaping the future of mental health through accredited education and responsible practice.
Facilitators from The Signs of Life Psychology, namely Dr. Lani Roy and Melissa Warner, will provide comprehensive training in PAT skills and will be supported by a range of leading academics, psychiatrists and clinicians in the space.
Dr Alana (Lani) Roy, Founder of The Signs of Life Psychology, is a psychologist, social worker, and therapist with extensive experience in mental health, suicide prevention, trauma, sexual abuse, family violence, and the disability sector. Lani provides Psychedelic Assisted Psychotherapy (PAP) for clients accessing ketamine treatment in Australia and is actively engaged in research trials focusing on psilocybin, empathogens, and Ayahuasca at Swinburne University. Specialising in complex trauma, disabilities, and dual diagnosis, Lani provides therapy in Auslan sign language for the Deaf community. She provides a range of educational and group-based psychedelic programs and is a board-approved psychology supervisor. Lani coordinates the psychedelic and plant medicine Mental Health Professional Network (MHPN) and has taught on Australian psychedelic programs. Lani has completed psychedelic Somatic Interactional Psychotherapy Training and is now extending this model to work from a Psychedelic Integrative Somatic approach, incorporating metacognitive and transpersonal domains. She is also the Australian chapter leader for the American Association for Psychedelic Medicines.
Melissa Warner is the Secretary of Psychedelic Research in Science and Medicine (PRISM), a pioneering Australian research charity where she helps advance research and science communication on psychedelics. She is also a neuroscience and psychology Research Fellow at Swinburne University, where she collaborates on psilocybin, 5-MeO-DMT, and virtual reality (VR) research. Melissa is a co-director of the Cyberdelic Society and Cyberdelic Labs, an extended-reality platform where she is an experience designer for virtual meditation adventures designed to train metacognition, mindset and mindfulness. She is designing research to explore the benefits of VR meditation before and after psychedelic-assisted therapy. Melissa also supports individuals as a meditation teacher at Signs of Life Psychology sharing her practice of meditation and coaching of 6+ years. In 2016, Melissa was a co-founder of The Australian Psychedelic Society, a grass-roots cultural hub. As a scientist, educator, futurist, and artist Melissa seeks to nurture the capacities of creativity, relationality and potentiality in herself and her community.
Melissa and Lani have designed educational training in psychedelic-assisted therapy for a number of local and international training institutions in the last four years. Melissa and Lani’s experience demonstrates immense passion, energy, capacity, and expertise in the psychedelic field. Lani and Melissa, along with the BIYOME team and our guest lecturers, are excited to share this offering of education, experience and community for the first time in 2024.
What You Will Walk Away With
Upon successfully completing this course and meeting the necessary skill prerequisites, you will acquire the proficiency to provide Psychedelic Assisted Therapy within the parameters of current regulatory government guidelines, fulfilling the roles of a Psychedelic Prescriber (PP), Psychedelic-Assisted Therapist (PAT), or Psychedelic Facilitator (PF). It’s important to note that for full accreditation as a Psychedelic Therapist, you must have eligibility for registration with a governing body such as:
Australian Health Practitioner Regulation Authority (AHPRA)
Australian Association of Social Workers (AASW)
Psychotherapy and Counselling Federation of Australia (PACFA)
Australian Counselling Association (ACA)
Indigenous Allied Health Australia (IAHA)
This Psychedelic-Assisted Therapy training equips individuals with a comprehensive skill set, including a deep understanding of the history of early psychedelic research and the contemporary resurgence in the ‘Psychedelic Renaissance.’ The curriculum explores Indigenous wisdom, providing insights into the historical use of plant medicines across Indigenous traditions worldwide. Practitioners will develop a foundational understanding of the pharmacology of psychedelics, neuroscience, and their mechanisms of action, coupled with the crucial skill of engaging in appropriate medical screening within a trauma-informed care framework. The training emphasises ethical considerations relevant to psychedelic facilitation, awareness of related laws and guidelines, and a focus on safety and risk mitigation.
Participants will master the intricacies of preparation and integration, covering medical assessment, clinical intake, intention setting, and managing expectations, with a specialised emphasis on somatic and trauma-focused approaches. The curriculum also encompasses harm reduction, spiritual emergence, and existential themes. Practitioners will develop space-holding skills, including characteristics of a facilitator, non-directiveness, attunement, and adept responses to challenging experiences. The program delves into the nuances of the therapeutic relationship, addressing topics such as managing boundaries, transference, countertransference, and self-care. Our program empowers you to walk away with a robust skill set, confidently navigating the complexities of psychedelic-assisted therapy.
Additionally, BIYOME’s Yoga Teacher Training courses offer a unique professional development avenue, allowing you to upgrade your current yoga teaching or therapy qualification with Yoga Australia by 200 hours.
Upon graduation, certification with BIYOME provides the opportunity to apply to register with both AMAPP and Yoga Australia, given completion of a minimum of 200 or 350 hours of core yoga teacher training skills.
DISCLAIMER: All applicants still need to undergo an individual accreditation process with AMAPP and are encouraged to reach out to AMAPP for any further questions about their individual learning context.
The field of psychedelics science and education is a new and emerging field. Participation in psychedelic medicine work in the legal community context with MDMA and Psilocybin is always dependent upon TGA and HREC protocol approvals and legislation requirements.
What You Will Experience
BIYOME courses have an initial application process for approval.
Students will be required to have a livestream group interview with the Foundational Team before beginning face-to-face training.
200hr Course Delivery over twelve (12) months:
* Blended learning approach with both online and in-person components.
* 65 per cent face-to-face contact and 35 per cent online learning.
Face-to-face learning – 130 hours.
* A small group interview with the foundational team via livestream.
* 4 x 50 hr Modules – 4 days each module & 16 days in-person training
(2 essential PAT modules and 2 complementary therapies electives)
* Expert-led lectures and practical demonstrations, experiential clinical skills, somatic integration work, trauma-informed compassion-focused mindfulness training – 112 hours
* Livestream Events with Foundational & Guest Lecturers – 18 hours of PAT specific livestream lectures, including a formal welcome seminar, screening, guest speakers.
* Online learning – multichoice assessments student online portal, PAT Introductory manual plus 4 x 50 hr manuals based on research and evidence-based PAT, pharmacology, medical screening, ethics, preparation and integration, space holding, therapeutic relationship, including the use of psychedelics in contemplative practice traditions & Indigenous wisdom, complementary therapies total – 70 hours online
* Clinical case studies
* Dosing and supervision. *For full registration in compliance with emerging Australian standards, graduates must complete an additional 12 hours external clinical supervision. Pathways provided by academic and clinic providers. Graduates of this training course can become preliminary registered. For full accreditation details, refer to AMAPP guidelines.
The four (4) x 50-hour modules are as follows:
PAT Training 100 hrs
**CPD23 Psychedelic Preparation & Integration Therapy for Allied Health Professionals (July 19-22, 2024)
**CPD27 Trauma-Informed Psychedelic Therapy Training:
Experiential Clinical Skills Training (March 28-31, 2025)
Complementary Therapies Training 100 hrs
(2 x 50 hr electives of choice from the following list)
(Please note you must be a qualified yoga and/or meditation teacher to teach yoga and meditation. Ask us more if you wish to teach or instruct beyond the basic skills of integration in a clinical setting).
**CPD03 Trauma-Informed Yoga Teacher Training: Compassion-based Yoga Therapy
**CPD06 Mindfulness for a Meaningful Life
**CPD10 Compassion-Focused Yoga Therapy and Meditation Teacher Training
**CPD24 Sound Healing Medicine: Multi-Instrument Training for Whole-Body Integration
Evidence of Dosing and Supervision:
To be registered to provide PAT legally, you are required to provide evidence or records related to dosing and supervision. We will work with you to source an approved accredited supervisor and/ or international equivalent.
Certification:
*Upon successful completion of the course, participants will receive a Certificate of Psychedelic Therapy & Integration Certification that can provide them with a pathway to apply for registration with AMAPP, showcasing their commitment to upholding the highest standards in psychedelic-assisted therapy. Graduates can apply to become preliminary registered with AMAPP. A student who wishes to engage in clinical supervision with an approved clinical PAT therapist and become fully registered, must find a PAT clinical supervisor to complete 12 hours minimum of clinical supervision to become fully registered with AMAPP.
DISCLAIMER: The PAT Graduate needs to find their own opportunities to meet full AMAPP registration requirements; this is not the responsibility of the BIYOME Institute.
However, academic course providers will provide the opportunity and support to work with them directly and/or recommend clinical supervision from a wide range of community referral lists.
Please read very carefully this AMAPP pathway to registration here for allied health professionals and check below for prerequisites for registration.
Please consult your peak membership bodies for regulatory requirements.
Note:
This course is designed to evolve with any future changes in TGA, HREC, and AMAPP guidelines to ensure continued alignment with the best practices in the field of Psychedelic-Assisted Therapy in Australia.
Taught By
Guest Lecturers for core skills training are included in the list below.
Other teachers for this course will vary depending on your selected electives. Complementary therapies teachers may have some or no association with Psychedelic Assisted Therapy.
Core Skills Training guest lecturers:
DR LANI ROY
Psychologist
Social Worker
Psychedelic Researcher & Advocate
Board Member of Australian Multidisciplinary Psychedelic Association Practitioners (AMAPP)
Research fellow at Swinburne University
MELISSA WARNER
Research fellow at Swinburne University
Secretary of Psychedelic Research in Science and Medicine (PRISM)
Neuroscientist
Psychedelic Medicine Integration Coach
Mindfulness Meditation Teacher
Virtual-Reality experience designer
PROFESSOR DR NIGEL STRAUSS
Psychedelic trial therapist
Psychiatrist & Clinical Associate, Swinburne University Melbourne
40 years in Psychiatry with special interest psychedelic-assisted psychotherapy
Honorary Research Fellow
DR DIANA KOREVAAR
Psychedelic trial therapist
Practising perinatal psychiatrist,
Mindfulness practitioner
Cognitive scientist exploring beliefs, self representation, and altered states of consciousness.
PROFESSOR SUSAN ROSSEL BSc(Hons) PhD
Psychedelic trial therapist
Professor of Cognitive Neuropsychiatry
NHMRC Senior Research Fellow at Swinburne University, Melbourne
Co-Chair of MAGNET – the Australian mental health clinical trial network.
Author
KIT KLINE
Nature Based Therapy
Masters in social work (MSW)
Masters of Indigenous Studies (University of South Australia)
Bachelor of Arts in Indigenous Studies (Victoria University).
Post Graduate Certificate in Mental Health
Accredited Mental Health First Aider
Compassionate Inquiry Supervisor
ATIRA TAN (ONLINE MATERIAL ONLY)
TedX speaker
Somatic Trauma Specialist
Therapist
Educator & Activist
Guest lecture from IPAT – Indigenous Psychedelic Assisted Therapies
Other guest lecturers to be announced.
Complementary Therapies Training
(optional electives facilitators)
CELIA ROBERTS BSc
Head Senior Yoga & Meditation Teacher
Yoga Therapist & Ayurvedic Practitioner
Director of BIYOME
EDWINA KEMPE
Licenced TCTSY Specialist
Social Worker
DR JAMES KIRBY
Lecturer in Clinical Psychology UQ School of Psychology
SAMANTHA LINDSAY-GERMAN
Kundalini Yoga
ANITA CASSIDY BOWMAN
Sound healing practitioner
SURAJ KHALSA
International Level 3 Lead Teacher Trainer & Mentor in Kundalini Yoga and Meditation.
CLAIRE STEPHENSEN
Registered Music Therapist Feminine Embodiment Coach
ALISA CRAIG
Breathwork Therapist
Four (4) x 50-hour modules:
PAT Training
CPD23 Psychedelic Preparation & Integration Therapy for Allied Health Professionals (July 19-22, 2024)
CPD27 Trauma-Informed Psychedelic Therapy Training: Experiential Clinical Skills Training (March 28-31, 2025)
Complementary Therapies Training
Selection of two (2) specialty intensive training electives from the list below:
CPD03 Trauma-Informed Yoga Teacher Training: Compassion-based Yoga Therapy (May 17-20, 2024)
CPD06 Mindfulness for a Meaningful Life (Year-round monthly Fridays 9:30-12:30; 11 consecutive classes for a 4-day course)
CPD10 Compassion Focused Yoga Therapy and Meditation Teacher Training (November 15-18, 2024)
CPD24 Sound Healing Medicine: Multi-Instrument Training for Whole-Body Integration (August 30 – September 2, 2024)
Detailed information on specialty intensive training electives (CPDs) is available here
This course allows the following Pathways to Accreditation to become a legally practising accredited PAT therapist:
Psychedelic Prescriber (PP),
Psychedelic-Assisted Therapist (PAT), or
Psychedelic Facilitator (PF).
It is currently a suitable pathway for registered Psychiatrists, Psychotherapists, Occupational Therapists, Counsellors, Social Workers, Naturopaths, Paramedics, Indigenous practitioners, Nurses, Physiotherapists, Mental Health Workers and Allied Health Professionals.
Somatic Therapists and Yoga and Meditation teachers need one of the qualifications above to legally practise or to be professionally registered with a suitable governing body.
For full accreditation as a Psychedelic Therapist, you must have eligibility for registration with a governing body such as:
Australian Health Practitioner Regulation Authority (AHPRA)
Australian Association of Social Workers (AASW)
Psychotherapy and Counselling Federation of Australia (PACFA)
Australian Counselling Association (ACA)
Indigenous Allied Health Australia (IAHA)
**Please contact us today to find out more
Face to face: https://biyome.com.au/course-pages/200pat/
Advertisement
Event Venue & Nearby Stays
166 Pacey Road, Upper Brookfield , Brisbane, QLD, Australia, Queensland 4069
